Healthcare-focused venture capital (VC) firm HealthQuad, which recently cashed out profitably from the Asian Institute of Nephrology and Urology, is positive about exit opportunities in India despite macro market headwinds.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
